SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Dopamine, glutamate, and gamma-aminobutyric acid: Key hubs in neurotransmitters, signal transduction, and cognitive dysfunction.

Neural Regen Res · 2026-05-14

DOI: 10.4103/nrr.nrr-d-25-00849PMID: 42199136

Check source for accessJournal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Neurotransmitters such as dopamine, glutamate, and gamma-aminobutyric acid (GABA) play crucial roles in regulating cognitive functions including learning, memory, and executive control. Dysregulation in synthesis, release, and metabolism of these neurotransmitters is implicated in the pathogenesis of various neurological disorders, such as Alzheimer's disease, Parkinson's disease, depression, and schizophrenia, leading to significant cognitive impairment. Recent research highlights that dopamine modulates reward processing, motivation, and memory through its synthesis via tyrosine hydroxylase and reuptake via the dopamine transporter. Glutamate, the primary excitatory neurotransmitter, mediates synaptic plasticity and cognitive processes through ionotropic and metabotropic receptors, while gamma-aminobutyric acid maintains inhibitory balance via GABA A and GABA B receptors. Notedly, interactions among these neurotransmitters, such as dopamine-Glu cross-talk through N-methyl-D-aspartate and dopamine receptors, and GABAergic regulation of dopaminergic activity, are critical for cognitive function. Existing detection techniques, including microdialysis, electrochemical sensors, and genetically encoded indicators, have advanced our understanding but still lack the spatiotemporal resolution needed to fully capture dynamic neurotransmitter interactions in real time. Although pharmacological interventions targeting these systems (e.g., L-3,4-dihydroxyphenylalanine, ketamine, GABAergic modulators) show potential, clinical applications are limited by significant side effects and variable efficacy. In summary, a multi-target approach, combining advanced detection methods with a deeper understanding of neurotransmitter crosstalk, may pave the way for more effective diagnostic and treatment interventions for cognitive disorders.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.